Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Financing at NeoTropiX

Dec. 15, 2004

TASQ enters clinical studies in prostate cancer patients

Dec. 15, 2004

Seliciclib induces apoptosis in multiple myeloma cell lines

Dec. 15, 2004

Tapestry advances development of lead oncolytic drugs

Dec. 14, 2004

Phase II glioblastoma multiforme study for 131I-TM-601

Dec. 14, 2004

Plasmin-specific inhibitor shows potent antiinvasive and antiangiogenic effects in vitro

Dec. 14, 2004

Preclinical studies support the use of AQ4N to treat lymphoproliferative diseases

Dec. 14, 2004

New phase I data on the antitumor effects and safety of talabostat

Dec. 14, 2004

Dabur researchers describe anticancer compounds

Dec. 13, 2004

Enrollment open in phase Ib study of ARQ-501 and Taxotere

Dec. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...